The objective of this study is to assess effect of oral Royal jelly on menopausal symptoms and sexual function in 50-60 years old menopausal women referred to selected health centers related to Iran University of Medical Sciences 2013- 2014. In a triple- blind, placebo- controlled trial, 110 menopausal aged 50-60 years, will be recruited and fill "Sabbatsberg Sexual Rating Scale (SSRS), Menopause Rating Scale (MRS) and personal characteristics" questionnaire, and will sign an Informed Consent from. Inclusion criteria: Not having physical and psychological diseases in women and their spouses, having coitus at least twice in a month, Not using of sedative and hypnotic drugs, HRT and herbal medicines more than once a week, Not allergic to honey consumption and BMI less than 28 kg m . Exclusion criteria: Not having sexual activity during the study, not using the drug under investigation for more than 6 days in a month, using of any hormonal and herbal medication, using of Soy more than one meal per week, starting any vegetarian diet and allergic and not using of Antibiotics or Antacids during the study. The participants will be randomly divided in intervention and control groups (55 women in each group). The intervention group will receive Royal Jelly, 100 mg capsule, once daily for two months and the control group will receive placebo capsule, at the same dose as the intervention group. After two months, Sabbatsberg Sexual Rating Scale and Menopause Rating Scale Scores will be measured again, compared and analyzed in the two groups before and after the intervention.